OS THERAPIES INCORPORATED Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- OS THERAPIES INCORPORATED stock issued during period, value, conversion of convertible securities for the quarter ending 2025-06-30 was $2.48M.
- OS THERAPIES INCORPORATED stock issued during period, value, conversion of convertible securities for the quarter ending 2024-09-30 was $24.76M.
- OS THERAPIES INCORPORATED stock issued during period, value, conversion of convertible securities for the quarter ending 2023-03-31 was $700.00K.
- OS THERAPIES INCORPORATED stock issued during period, value, conversion of convertible securities for fiscal 2024 was $24.76M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2025-06-30 | $2.48M 10-Q · filed 2025-08-18 | |
| 2024-12-31 | $24.76M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $24.76M 10-Q · filed 2025-11-14 | |
| 2023-03-31 | $700.00K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |